Intermittent intravenous ibandronate therapy for osteoporosis
The author consecutively considers the introduction of intermittent use of ibandronate (I), by determining its single dose and annual cumulative dose. She presents data on the adequate antiresorptive activity of intermittent treatment, shows it necessary to design an intravenous dosage form of the d...
Saved in:
| Main Authors: | L I Alekseeva, L I Alekseyeva |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2008-09-01
|
| Series: | Современная ревматология |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/175 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
VIBE: Evaluation of Ibandronate Efficacy - Original Investigation
by: J-Y Reginster, et al.
Published: (2008-12-01) -
Review of once-monthly oral ibandronate and the use thereof
by: T De Villiers, et al.
Published: (2017-08-01) -
Novel Approaches to Monitor Pharmacokinetics and Metabolism of Gemcitabine-Ibandronate Conjugate in Mice and Dogs
by: Jost Klawitter, et al.
Published: (2025-01-01) -
EFFECT OF IBANDRONATE ON RISKS FOR VERTEBRAL AND NONVERTEBRAL FRACTURES IN POSTMENOPAUSALOSTEOPOROSIS (A REVIEW OF CLINICAL TRIALS)
by: Evgeni Germanovich Zotkin
Published: (2010-06-01) -
A Case Report of Ibandronic Acid Induced Non-Exposed BRONJ Involving the Maxillary Sinus
by: Ioannis Fotopoulos, et al.
Published: (2023-12-01)